The DOI matches its Crossref record; 282 of the 282 references it cites were found in a registry or an index.
Psychosocial interventions for stimulant use disorder
Open accessAbstract
BACKGROUND: Stimulant use disorder is a continuously growing medical and social burden without approved medications available for its treatment. Psychosocial interventions could be a valid approach to help people reduce or cease stimulant consumption. This is an update of a Cochrane review first published in 2016. OBJECTIVES: To assess the efficacy and safety of psychosocial interventions for stimulant use disorder in adults. SEARCH METHODS: We searched the Cochrane Drugs and Alcohol Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, three other databases, and two trials registers in September 2023. All searches included non-English language literature. We handsearched the references of topic-related systematic reviews and the included studies. SELECTION CRITERIA: We included randomised controlled trials (RCTs) comparing any psychosocial intervention with no intervention, treatment as usual (TAU), or a different intervention in adults with stimulant use disorder. DATA COLLECTION AND ANALYSIS: We used the standard methodological procedures expected by Cochrane. MAIN RESULTS: We included a total of 64 RCTs (8241 participants). Seventy-three percent of studies included participants with cocaine or crack cocaine use disorder; 3.1% included participants with amphetamine use disorder; 10.9% included participants with methamphetamine use disorder; and 12.5% included participants with any stimulant use disorder. In 18 studies, all participants were in methadone maintenance treatment. In our primary comparison of any psychosocial treatment to no intervention, we included studies which compared a psychosocial intervention plus TAU to TAU alone. In this comparison, 12 studies evaluated cognitive behavioural therapy (CBT), 27 contingency management, three motivational interviewing, one study looked at psychodynamic therapy, and one study evaluated CBT plus contingency management. We also compared any psychosocial intervention to TAU. In this comparison, seven studies evaluated CBT, two contingency management, two motivational interviewing, and one evaluated a combination of CBT plus motivational interviewing. Seven studies compared contingency management reinforcement related to abstinence versus contingency management not related to abstinence. Finally, seven studies compared two different psychosocial approaches. We judged 65.6% of the studies to be at low risk of bias for random sequence generation and 19% at low risk for allocation concealment. Blinding of personnel and participants was not possible for the type of intervention, so we judged all the studies to be at high risk of performance bias for subjective outcomes but at low risk for objective outcomes. We judged 22% of the studies to be at low risk of detection bias for subjective outcomes. We judged most of the studies (69%) to be at low risk of attrition bias. When compared to no intervention, we found that psychosocial treatments: reduce the dropout rate (risk ratio (RR) 0.82, 95% confidence interval (CI) 0.74 to 0.91; 30 studies, 4078 participants; high-certainty evidence); make little to no difference to point abstinence at the end of treatment (RR 1.15, 95% CI 0.94 to 1.41; 12 studies, 1293 participants; high-certainty evidence); make little to no difference to point abstinence at the longest follow-up (RR 1.22, 95% CI 0.91 to 1.62; 9 studies, 1187 participants; high-certainty evidence); probably increase continuous abstinence at the end of treatment (RR 1.89, 95% CI 1.20 to 2.97; 12 studies, 1770 participants; moderate-certainty evidence); may make little to no difference in continuous abstinence at the longest follow-up (RR 1.14, 95% CI 0.89 to 1.46; 4 studies, 295 participants; low-certainty evidence); reduce the frequency of drug intake at the end of treatment (standardised mean difference (SMD) -0.35, 95% CI -0.50 to -0.19; 10 studies, 1215 participants; high-certainty evidence); and increase the longest period of abstinence (SMD 0.54, 95% CI 0.41 to 0.68; 17 studies, 2118 participants; high-certainty evidence). When compared to TAU, we found that psychosocial treatments reduce the dropout rate (RR 0.79, 95% CI 0.65 to 0.97; 9 studies, 735 participants; high-certainty evidence) and may make little to no difference in point abstinence at the end of treatment (RR 1.67, 95% CI 0.64 to 4.31; 1 study, 128 participants; low-certainty evidence). We are uncertain whether they make any difference in point abstinence at the longest follow-up (RR 1.31, 95% CI 0.86 to 1.99; 2 studies, 124 participants; very low-certainty evidence). Compared to TAU, psychosocial treatments may make little to no difference in continuous abstinence at the end of treatment (RR 1.18, 95% CI 0.92 to 1.53; 1 study, 128 participants; low-certainty evidence); probably make little to no difference in the frequency of drug intake at the end of treatment (SMD -1.17, 95% CI -2.81 to 0.47, 4 studies, 479 participants, moderate-certainty ev
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–282 of 282
Toward cost-effective initial care for substance-abusing homeless
Milby, J. B., Schumacher, J. E., Vuchinich, R. E., Freedman, M. J., Kertesz, S. G., & Wallace, D. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.03.003 · Cited by 43
Psychosocial interventions for psychostimulant misuse
Minozzi, S., Crescenzo, F. D., Saulle, R., & Amato, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011866 · Cited by 43
Self-citationRosenblum, A., Magura, S., Kayman, D. J., & Fong, C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.03.012 · Cited by 42
Secades‐Villa, R., García–Fernández, G., Peña-Suárez, E., García–Rodríguez, O., Sánchez‐Hervás, E., & Hermida, J. R. F. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.08.018 · Cited by 42
Tran, M. T. N., Luong, Q. H., Le Minh, G., Dunne, M. P., & Baker, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.512076 · Cited by 42
McKay, J., Horn, D. V., Lynch, K., Ivey, M. A., Cary, M. S., Drapkin, M. L., Coviello, D. M., & Plebani, J. G. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0034265 · Cited by 41
Glasner, S. V., Tate, S. R., McQuaid, J. R., Cummins, K. M., Granholm, E. L., & Brown, S. A. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.663 · Cited by 41
Dürsteler‐MacFarland, K. M., Farronato, N. S., Strasser, J., Boss, J., Kuntze, M. F., Petitjean, S. A., Bürki, C., & Wiesbeck, G. A. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31827bfff4 · Cited by 41
A Randomized Controlled Trial of a Money Management-Based Substance Use Intervention
Rosen, M. I., Carroll, K. M., Stefanovics, E. A., & Rosenheck, R. A. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.4.498 · Cited by 41
Contingency Management for Stimulant Use Disorder: Progress, Challenges, and Recommendations
Rawson, R. A., Erath, T. G., Chalk, M., Clark, H. W., McDaid, C., Wattenberg, S. A., Roll, J. M., McDonell, M. G., Parent, S., & Freese, T. E. (2023) · Journal of Ambulatory Care Management · doi:10.1097/jac.0000000000000450 · Cited by 41
Petry, N. M., Alessi, S. M., Barry, D., & Carroll, K. M. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0037888 · Cited by 40
Klimas, J., Fairgrieve, C., Tobin, H., Field, C.-A., O'Gorman, C. S., Glynn, L. G., Keenan, E., Saunders, J., Bury, G., Dunne, C., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009269.pub4 · Cited by 40
Xu, X., Ding, X., Chen, L., Chen, T., Su, H., Li, X., Ye, Y., Shi, W., Ji, J., Zhao, M., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.056 · Cited by 40
The Role of Node-Link Mapping in Individual and Group Counseling
Knight, D. K., Dansereau, D. F., Joe, G. W., & Simpson, D. D. (1994) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999409109187 · Cited by 39
Carrico, A. W., Jain, J. P., Discepola, M. V., Olem, D., Andrews, R., Woods, W. J., Neilands, T. B., SHOPTAW, S. J., Gómez, W., Dilworth, S. E., et al. (2016) · BMC Public Health · doi:10.1186/s12889-016-3325-1 · Cited by 39
Detoxification treatments for opiate dependent adolescents
Minozzi, S., Amato, L., Bellisario, C., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006749.pub3 · Cited by 37
Self-citationMimiaga, M. J., Pantalone, D. W., Biello, K. B., Glynn, T. R., Santostefano, C. M., Olson, J., Pardee, D. J., Hughto, J. M. W., Valles, J. G., Carrico, A. W., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5856-0 · Cited by 37
Effectiveness of psychosocial interventions for reducing parental substance misuse
McGovern, R., Newham, J. J., Addison, M. T., Hickman, M., & Kaner, E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012823.pub2 · Cited by 37
Rewarding early abstinence in Veterans Health Administration addiction clinics
Hagedorn, H., Noorbaloochi, S., Simon, A. B., Bangerter, A. K., Stitzer, M. L., Stetler, C. B., & Kivlahan, D. R. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.01.006 · Cited by 35
Continuity of Care and Desipramine in Primary Cocaine Abusers
Hall, S. M., Tunis, S. L., Triffleman, E., Banys, P., CLARK, H. W., Tusel, D. J., Stewart, P., & Presti, D. E. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199410000-00007 · Cited by 35
Diethylpropion Pharmacotherapeutic Adjuvant Therapy for Inpatient Treatment of Cocaine Dependence
Alim, T. N., Rosse, R. B., Vocci, F. J., Lindquist, T., & Deutsch, S. I. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199504000-00009 · Cited by 34
Neurobehavioral Treatment for Cocaine-Using Methadone Patients:
Magura, S., Rosenblum, A., Lovejoy, M., Handelsman, L., Foote, J. P., & Stimmel, B. (1995) · Journal of Addictive Diseases · doi:10.1300/j069v13n04_03 · Cited by 34
Glasner, S. V., Patrick, K., Ybarra, M. L., Reback, C. J., Ang, A., Kalichman, S. C., Bachrach, K., Garneau, H. C., Venegas, A., & Rawson, R. A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109229 · Cited by 34
Haasen, C., Prinzleve, M., Gossop, M., Fischer, G., & Casas, M. (2005) · PubMed Central · Cited by 33
Ghitza, U. E., Epstein, D., Schmittner, J., Vahabzadeh, M., Lin, J.-L., & Preston, K. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.5.765 · Cited by 33
Petry, N. M., Alessi, S. M., Rash, C. J., Barry, D., & Carroll, K. M. (2018) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000330 · Cited by 33
Behavioral therapy across the spectrum.
Witkiewitz, K. A., & Marlatt, A. G. (2011) · Europe PMC (PubMed Central) · Cited by 32
Mapping-enhanced drug abuse counseling: Urinalysis results in the first year of methadone treatment
Dees, S. M., Dansereau, D. F., & Simpson, D. D. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(96)00163-8 · Cited by 32
Degenhardt, L. J., Day, C., Hall, W., Conroy, E., & Gilmour, S. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-40 · Cited by 31
Aharonovich, E., Sarvet, A., Stohl, M., DesJarlais, D., Tross, S., Hurst, T., Urbina, A., & Hasin, D. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.12.009 · Cited by 30
Contingency Management is Efficacious for Cocaine Abusers with Prior Treatment Attempts
Rash, C. J., Alessi, S. M., & Petry, N. (2008) · Experimental and clinical psychopharmacology · doi:10.1037/a0014042 · Cited by 29
A dose response study of cognitive behavioral therapy in cocaine abusers
Covi, L., Hess, J. M., Schroeder, J. R., & Preston, K. L. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00247-7 · Cited by 29
Ghitza, U. E., Epstein, D., & Preston, K. (2008) · Addictive Behaviours · doi:10.1016/j.addbeh.2007.11.009 · Cited by 27
Preston, K., Ghitza, U. E., Schmittner, J., Schroeder, J., & Epstein, D. (2008) · Journal of Applied Behavior Analysis · doi:10.1901/jaba.2008.41-551 · Cited by 27
Petry, N. M., Alessi, S. M., & Rash, C. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.017 · Cited by 27
Landovitz, R. J., Fletcher, J. B., SHOPTAW, S. J., & Reback, C. J. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu114 · Cited by 27
[Effect of incentives on retention in an outpatient treatment for cocaine addicts].
García–Rodríguez, O., Secades‐Villa, R., Rodríguez, H. Á., Rodríguez, A. R., Hermida, J. R. F., Carballo, J. L., Pérez, J. M. E., & Díaz, S. A.-H. (2007) · PubMed · Cited by 26
García–Fernández, G., Secades‐Villa, R., García–Rodríguez, O., Sánchez‐Hervás, E., Hermida, J. R. F., & Higgins, S. T. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00154.x · Cited by 26
Gross, A., Marsch, L., Badger, G., & Bickel, W. (2006) · Experimental and clinical psychopharmacology · doi:10.1037/1064-1297.14.2.148 · Cited by 26
Who benefits from extended continuing care for cocaine dependence?
McKay, J. R., Van Horn, D. H. A., Lynch, K. G., Ivey, M., Cary, M. S., Drapkin, M., & Coviello, D. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.019 · Cited by 26
Falck, R. S., Wang, J., Siegal, H. A., & Carlson, R. G. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400494 · Cited by 26
Randomized comparison of intensive outpatient vs. individual therapy for cocaine abusers.
Weinstein, S. P., Gottheil, E., & Sterling, R. C. (1997) · Journal of Addictive Diseases · doi:10.1300/j069v16n02_04 · Cited by 26
Marsden, J., Goetz, C., Meynen, T., Mitcheson, L., Stillwell, G., Eastwood, B., Strang, J., & Grey, N. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.039 · Cited by 26
Correlates of Stimulant Treatment Outcome Across Treatment Modalities
Peirce, J. M., Petry, N. M., Roll, J. M., Kolodner, K., Krasnansky, J., Stabile, P. Q., Brown, C., & Stitzer, M. L. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802455444 · Cited by 25
Hall, S. M., Cooper, J. L., Burmaster, S., & Polk, A. (1977) · Behaviour Research and Therapy · doi:10.1016/0005-7967(77)90049-3 · Cited by 25
Ghitza, U. E., Epstein, D., Schmittner, J., Vahabzadeh, M., Lin, J.-L., & Preston, K. (2008) · Journal of Applied Behavior Analysis · doi:10.1901/jaba.2008.41-539 · Cited by 25
Miguel, A. C., Madruga, C. S., Cogo‐Moreira, H., Yamauchi, R., Simões, V., Ribeiro, A., da Silva, C. J., Fruci, A., McDonell, M. G., McPherson, S., et al. (2017) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000147 · Cited by 25
A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence
Keoleian, V., Stalcup, S. A., Polcin, D. L., Brown, M. J., & Galloway, G. P. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.847995 · Cited by 23
Farabee, D., Rawson, R., & McCann, M. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00297-0 · Cited by 22
Chen, K. W., Berger, C. C., Gandhi, D. H., Weintraub, E., & Lejuez, C. W. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0311 · Cited by 22
Horn, D. H. A. V., Drapkin, M. L., Ivey, M. A., Thomas, T., Domis, S. W., Abdalla, O., Herd, D., & McKay, J. R. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.007 · Cited by 20
Holtyn, A. F., Toegel, F., Subramaniam, S., Jarvis, B. P., Leoutsakos, J., Fingerhood, M. I., & Silverman, K. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2020-213761 · Cited by 20
Knealing, T. W., Wong, C. J., Diemer, K. N., Hampton, J., & Silverman, K. (2006) · Experimental and clinical psychopharmacology · doi:10.1037/1064-1297.14.3.350 · Cited by 19
Effectiveness of psychosocial interventions for reducing parental substance misuse
McGovern, R., Addison, M. T., Newham, J. J., Hickman, M., & Kaner, E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012823 · Cited by 19
García–Fernández, G., Secades‐Villa, R., García–Rodríguez, O., Álvarez-López, H., Hermida, J. R. F., Fernández‐Artamendi, S., & Higgins, S. T. (2011) · European Addiction Research · doi:10.1159/000324848 · Cited by 18
Alammehrjerdi, Z., Briggs, N., Biglarian, A., Mokri, A., & Dolan, K. A. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1578445 · Cited by 18
Miguel, A. C., McPherson, S., Simões, V., Yamauchi, R., Madruga, C. S., Smith, C. L., da Silva, C. J., Laranjeira, R., McDonell, M. G., Roll, J. M., et al. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103464 · Cited by 18
Bahrami, S., & Asghari, F. (2017) · Archives of Psychiatry and Psychotherapy · doi:10.12740/app/68159 · Cited by 17
Burduli, E., Skalisky, J., Hirchak, K., Orr, M. F., Foote, A., Granbois, A., Ries, R., Roll, J. M., Buchwald, D., McDonell, M. G., et al. (2018) · Clinical Trials · doi:10.1177/1740774518796151 · Cited by 17
Contingency management for substance use disorders in Spain: Implications for research and practice
Secades‐Villa, R., García–Rodríguez, O., & Hermida, J. R. F. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.07.001 · Cited by 16
Schaub, M. P., Castro, R. P., Wenger, A., Baumgartner, C., Stark, L., Ebert, D. D., Quednow, B. B., & Haug, S. (2019) · Internet Interventions · doi:10.1016/j.invent.2019.100251 · Cited by 16
Schaub, M. P., Maier, L. J., Wenger, A., Stark, L., Berg, O., Beck, T., Quednow, B. B., & Haug, S. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0518-6 · Cited by 15
Blanken, P., Hendriks, V. M., Huijsman, I. A., van Ree, J. M., & van den Brink, W. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.04.018 · Cited by 15
Mitcheson, L., McCambridge, J., & Byrne, S. (2006) · European Addiction Research · doi:10.1159/000095809 · Cited by 14
Marsden, J., Goetz, C., Meynen, T., Mitcheson, L., Stillwell, G., Eastwood, B., Strang, J., & Grey, N. (2017) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2017.10.009 · Cited by 14
Najavits, L. M., Enggasser, J. L., Brief, D. J., & Federman, E. J. (2018) · American Journal on Addictions · doi:10.1111/ajad.12709 · Cited by 14
Ruger, J. P., Abdallah, A. B., Luekens, C., & Cottler, L. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033594 · Cited by 14
McKay, J. R., Van Horn, D., Ivey, M., Drapkin, M. L., Rennert, L., & Lynch, K. G. (2013) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2013.74.642 · Cited by 13
A randomized comparison of 4 vs. 16 weeks of psychosocial treatment for stimulant users
Rawson, R. A., Glasner, S. V., Brecht, M., & Farabee, D. J. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108274 · Cited by 13
Secades‐Villa, R., Sánchez‐Hervás, E., Romaguera, F. Z., García–Rodríguez, O., Gómez, F. J. S., & García–Fernández, G. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00250.x · Cited by 11
Sorsdahl, K., Stein, D. J., Pasche, S., Jacobs, Y., Kader, R., Odlaug, B., Richter, S., Myers, B., & Grant, J. E. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00209-3 · Cited by 11
Tardelli, V., Berro, L. F., Gerra, G., Tadonio, L., Bisaga, A., & Fidalgo, T. (2023) · Addiction Biology · doi:10.1111/adb.13271 · Cited by 11
Brief Interventions to Reduce Ecstasy Use: A Multi-Site Randomized Controlled Trial
Norberg, M. M., Hides, L. M., Olivier, J., Khawar, L., McKetin, R., & Copeland, J. (2014) · Behavior Therapy · doi:10.1016/j.beth.2014.05.006 · Cited by 10
Lack of Neurotoxic Effect of Diethylpropion in Crack-Cocaine Abusers
Ollo, C., Alim, T. N., Rosse, R. B., Lindquist, T., Green, T., Gillis, T., Ricci, J., Khan, M., & Deutsch, S. I. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619010-00003 · Cited by 10
Worley, M. J., Gallop, R., Gibbons, M. B. C., Ring‐Kurtz, S., Present, J., Weiss, R. D., & Crits-Christoph, P. F. (2008) · American Journal on Addictions · doi:10.1080/10550490802021994 · Cited by 10
A pilot randomized trial of CBT4CBT for women in residential treatment for substance use disorders
Kelpin, S. S., Parlier-Ahmad, A. B., Jallo, N., Carroll, K., & Svikis, D. S. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108622 · Cited by 10
Pirnia, B., Tabatabaei, S. K. R., Tavallaii, A., Soleimani, A. A., & Pirnia, K. (2016) · Electronic physician · doi:10.19082/3214 · Cited by 7
A Novel Therapy for cocaine dependence during abstinence: A randomized clinical trial
Pirnia, B., Moradi, A. R., Pirnia, K., Kolahi, P., & Roshan, R. (2017) · Electronic physician · doi:10.19082/4862 · Cited by 7
Blevins, D., Carpenter, K. M., Martínez, D., Mariani, J. J., & LEVIN, F. R. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106187 · Cited by 4
Mallorquí‐Bagué, N., Palazón-Llecha, A., Madre, M., Batlle, F., Duran‐Sindreu, S., & Trujols, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1051528 · Cited by 4
Behavioral incentives to promote exercise compliance in cocaine-dependent women
Islam, L. Z., & Svikis, D. S. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.09.314 · Cited by 3
HealthCall: Technology use to reduce non-injection drug use in HIV primary care
Aharonovich, E., Hasin, D. S., & Stohl, M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.07.927 · Cited by 1
Research works printed but not linked: 17
- Crits-Christoph, 1999, Psychosocial treatments for cocaine dependence: National Institute of Drug Abuse Collaborative Cocaine Treatment Study, Archives of General Psychiatry, 56, 493, 10.1001/archpsyc.56.6.493 · DOI
- Higgins, 1995, Outpatient behavioral treatment for cocaine dependence. one-year outcome, Experimental and Clinical Psychopharmacology, 3, 205, 10.1037/1064-1297.3.2.205 · DOI
- Farabee, 2002, Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments, Journal of Substance Abuse Treatment, 23, 343, 10.1016/S0740-5472(02)00297-0 · DOI · Paper page
- Farabee, 2002, Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments, Journal of Substance Abuse Treatment, 23, 343, 10.1016/S0740-5472(02)00297-0 · DOI · Paper page
- Farabee, 2002, Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments, Journal of Substance Abuse Treatment, 23, 343, 10.1016/S0740-5472(02)00297-0 · DOI · Paper page
- Sanchez-Hervas, 2008, Psychological treatment for cocaine addicts in public health services, Trastornos adictivos, 10, 275
- Sanchez-Hervas, 2008, Community reinforcement approach (CRA) for cocaine addicts: establishment in a public health setting, Anales de Psiquiatria, 24, 153
- Shoptaw, 2005, Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men, Drug and Alcohol Dependence, 78, 125, 10.1016/j.drugalcdep.2004.10.004 · DOI · Paper page
- Shoptaw, 2005, Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men., Drug and Alcohol Dependence, 78, 125, 10.1016/j.drugalcdep.2004.10.004 · DOI · Paper page
- Kalapatapu R Cognitive rehabilitation for cocaine use disorder Dissertation submitted in partial satisfaction of the requirements for degree of Doctor of Philosophy 2021
- Beck, 1996, Manual for the Beck Depression Inventory-II
- Committee on developing evidence-based standards for psychosocial interventions for Mental Disorders, 2015, Psychosocial interventions for mental and substance use disorders: a framework for establishing evidence-based standards
- Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org/handbook
- Higgins JPT Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org/handbook
- Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org
- Miller, 1992, Motivational enhancement therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence
- United Nations Office on Drugs and Crime, 2022, World Drug Report
Cited by
Sorted by citations
Knock, E., Siefried, K. J., Bedi, G., Albert, S., Day, R. O., Ezard, N., Ross, M., Liknaitzky, P., & Brett, J. (2025) · Addiction · doi:10.1111/add.70187 · Cited by 9
Brett, J., Knock, E., Watson, K., Albert, S., Siefried, K. J., & Guss, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1490907 · Cited by 7
“Psychosocial therapies for MA dependence generally do not require withdrawal management prior to treatment initiation in most community settings (8).”
Emerging medications and pharmacological treatment approaches for substance use disorders
Raymond, J. S., Athanasopoulos, A. G., Badolato, C. J., Doolan, T. M., Scicluna, R. L., Everett, N. A., Bowen, M. T., & James, M. H. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173952 · Cited by 9
“…evidence indicates that CBT does not significantly improve abstinence from stimulant use compared to usual care (Farrell et al., 2019; De Crescenzo et al., 2018; Minozzi et al., 2024), and demonstrates high levels of attrition (i.e., 70% at 12 weeks) (Smout et al., 2010; Lappan et al., 2020).”
Barkus, A., Baltrūnienė, V., Barkienė, L., Baušienė, J., Baltrūnas, T., Brazys, M., Rauduvytė, K., Kazlauskaitė, P., & Baušys, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70165 · Cited by 7
Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023
Harris, R. A., Khatana, S. A. M., Glei, D. A., & Long, J. A. (2025) · Substance Use Research and Treatment · doi:10.1177/29768357251342744 · Cited by 4
Metadata
- Authors
- Minozzi, S., Saulle, R., Amato, L., Traccis, F., & Agabio, R.
- Affiliations
- Regione Lazio (IT)
- University of Cagliari (IT)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2024-02-15
- Volume
- 2024
- Issue
- 2
- Pages
- CD011866-CD011866
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC10867898
- OpenAlex
- W4391840511
- Cited by
- 32
- References
- 280
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 6
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- National Institutes of Health (AA03510)
- National Institute on Drug Abuse (DA09241., P50DA009241, P50-DA-0-9241, R01DA013444)
- National Center for Research Resources (M01RR006192)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- stimulant use disorder, psychosocial interventions, cocaine dependence, crack cocaine, amphetamine use disorder, methamphetamine, cognitive behavioral therapy, contingency management, motivational interviewing, psychodynamic psychotherapy, methadone maintenance treatment, treatment efficacy, treatment safety, relapse, treatment discontinuation, medication adherence, treatment acceptability
- MeSH terms
- Psychosocial Intervention, Adult, Counseling, Humans, Cognitive Behavioral Therapy, Substance-Related Disorders, Motivational Interviewing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review